Basic Information
| LncRNA/CircRNA Name | DLG2AS |
| Synonyms | DLG2-AS1, DLG2-AS, DLG2AS, PSZA11q14, SZ-1 |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | Microarray, qPCR etc. |
| Sample | HCC tissues |
| Expression Pattern | down-regulated |
| Function Description | The majority (14 out of 17) of these lncRNAs were confirmed to be dysregulated in HCC compared to the surrounding non-tumorous tissues, corroborating the reliability of our profiling data. |
| Pubmed ID | 27894309 |
| Year | 2016 |
| Title | Analysis of long noncoding RNA expression in hepatocellular carcinoma of different viral etiology. |
External Links
| Links for DLG2AS | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |